Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vir Biotechnology Inc.

    NASDAQ: VIR · Real-Time Price · USD
    5.24
    0.02 (0.38%)
    At close: Jun 16, 2025, 3:59 PM
    5.14
    -1.81%
    After-hours: Jun 16, 2025, 05:22 PM EDT

    Vir Biotechnology Statistics

    Share Statistics

    Vir Biotechnology has 138.24M shares outstanding. The number of shares has increased by 0.8% in one year.

    Shares Outstanding

    n/a
    		 138.24M

    Shares Change (YoY)

    n/a
    		 0.8%

    Shares Change (QoQ)

    n/a
    		 -0.42%

    Owned by Institutions (%)

    n/a
    		 64.98%

    Shares Floating

    n/a
    		 89.08M

    Failed to Deliver (FTD) Shares

    n/a
    		 17

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 11.52M, so 8.33% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.52M

    Short % of Shares Out

    n/a
    		 8.33%

    Short % of Float

    n/a
    		 13.47%

    Short Ratio (days to cover)

    n/a
    		 7.55

    Valuation Ratios

    The PE ratio is -1.92 and the forward PE ratio is -1.69. Vir Biotechnology's PEG ratio is 0.12.

    PE Ratio

    n/a
    		 -1.92

    Forward PE

    n/a
    		 -1.69

    PS Ratio

    n/a
    		 13.48

    Forward PS

    n/a
    		 3.9

    PB Ratio

    n/a
    		 0.87

    P/FCF Ratio

    n/a
    		 -2.2

    PEG Ratio

    n/a
    		 0.12
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vir Biotechnology.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 8.71, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 8.71

    Quick Ratio

    n/a
    		 8.71

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 -0.18

    Debt / FCF

    n/a
    		 -0.22

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $181,875

    Profits Per Employee

    n/a
    		 $-1,279,313.73

    Employee Count

    n/a
    		 408

    Asset Turnover

    n/a
    		 0.05

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -1.15M

    Effective Tax Rate

    n/a
    		 0.22%

    Stock Price Statistics

    The stock price has increased by -42.92% in the last 52 weeks. The beta is 1.23, so Vir Biotechnology's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.23

    52-Week Price Change

    n/a
    		 -42.92%

    50-Day Moving Average

    n/a
    		 5.34

    200-Day Moving Average

    n/a
    		 7.52

    Relative Strength Index (RSI)

    n/a
    		 50.2

    Average Volume (20 Days)

    n/a
    		 1,347,725

    Income Statement

    In the last 12 months, Vir Biotechnology had revenue of 74.2M and earned -521.96M in profits. Earnings per share was -3.83.

    Revenue

    n/a
    		 74.2M

    Gross Profit

    n/a
    		 73.36M

    Operating Income

    n/a
    		 -587.16M

    Net Income

    n/a
    		 -521.96M

    EBITDA

    n/a
    		 -537.61M

    EBIT

    n/a
    		 -552.17M

    Earnings Per Share (EPS)

    n/a
    		 -3.83
    Full Income Statement

    Balance Sheet

    The company has 312.33M in cash and 97.89M in debt, giving a net cash position of 214.44M.

    Cash & Cash Equivalents

    n/a
    		 312.33M

    Total Debt

    n/a
    		 97.89M

    Net Cash

    n/a
    		 214.44M

    Retained Earnings

    n/a
    		 -759.78M

    Total Assets

    n/a
    		 1.31B

    Working Capital

    n/a
    		 794.92M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -446.35M and capital expenditures -7.3M, giving a free cash flow of -453.65M.

    Operating Cash Flow

    n/a
    		 -446.35M

    Capital Expenditures

    n/a
    		 -7.3M

    Free Cash Flow

    n/a
    		 -453.65M

    FCF Per Share

    n/a
    		 -3.33
    Full Cash Flow Statement

    Margins

    Gross margin is 98.86%, with operating and profit margins of -791.27% and -703.4%.

    Gross Margin

    n/a
    		 98.86%

    Operating Margin

    n/a
    		 -791.27%

    Pretax Margin

    n/a
    		 -704.95%

    Profit Margin

    n/a
    		 -703.4%

    EBITDA Margin

    n/a
    		 -724.49%

    EBIT Margin

    n/a
    		 -791.27%

    FCF Margin

    n/a
    		 -611.35%

    Dividends & Yields

    VIR does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for VIR is $20, which is 281.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $20

    Price Target Difference

    n/a
    		 281.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 7
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -0.1

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist